SPECIFIC Kidney Support FKW-P

SPECIFIC FKW Kidney Support FKW-P

+ Indications:

• Chronic Renal insufficiency
• Liver failure (except cholestasis patients)
• Congestive heart failure, hypertension, edema
• Urate, oxalate or cystine urolithiasis.

Properties:

The phosphorus content is reduced to prevent hyperphosphatemia and slow the progression of Renal insufficiency.

EPA and DHA are omega-3 fatty acids that help slow the progression of Renal insufficiency in renal patients. In cats with heart disease, omega-3 fatty acids counteract cachexia and reduce hypertension and platelet aggregation.

The reduced protein content, combined with the high biological value of the proteins, reduces azotemia in kidney patients. In cats with liver insufficiency, the likelihood of hyperammonemia and possible hepatic encephalopathy is also reduced. The high-quality protein meets the patient's need for essential amino acids.

In congestive heart failure, sodium excretion is reduced to compensate for the reduced stroke volume, which directly results in sodium and water retention. The reduced sodium content helps to break this vicious circle of water retention (hypertension and edema).

The low protein content reduces the urine concentration of oxalate, cystine and urate. The induced, slightly alkaline urine pH value combats the precipitation of urate and cystine crystals. The presence of additional K-citrate reduces the risk of calcium oxalate precipitation.